CS logo
small CS logo
Kentucky Eye Institute

Lexington, Kentucky, United States
Eye care center in Lexington, Kentucky
601 Perimeter Dr Suite 100, Lexington, KY 40517

About Kentucky Eye Institute


"Since 1970, Kentucky Eye Institute has provided world-class comprehensive eye care to the central, northern, eastern, and southern Kentucky regions. With nine office locations, Kentucky Eye Institute is easily accessible to most patients. Our goal is to be your provider of choice for surgical and consultative intervention. At KEI, we have a vision for excellence and a heart for service."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Kentucky Eye Institute


During the past decade, Kentucky Eye Institute conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 4 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based Chemotherapy
2009-09-30
2017-11-02
Completed
1,199
A Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate Cancer
2010-09-16
2019-02-14
Completed
1,717
A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study)
2013-10-14
2021-03-05
Completed
431
Efficacy and Safety of Idelalisib in Combination With Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia With 17p Deletion
2014-08-06
2016-05-17
Terminated
102
A Study of Carboplatin, Pemetrexed Plus Placebo vs Carboplatin, Pemetrexed Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With Non-Squamous Non-Small Cell Lung Cancer
2015-02-01
2017-04-07
Completed
82
Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)
2014-12-17
2026-09-19
Active, not recruiting
1,068
A Study of Atezolizumab in Combination With Bevacizumab Versus Sunitinib in Participants With Untreated Advanced Renal Cell Carcinoma (RCC)
2015-05-20
2021-12-13
Completed
915
A Study of Atezolizumab in Combination With Nab-Paclitaxel Compared With Placebo With Nab-Paclitaxel for Participants With Previously Untreated Metastatic Triple-Negative Breast Cancer (IMpassion130)
2015-06-23
2021-08-31
Completed
902

Rows per page:

1–18 of 18

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Kentucky Eye Institute" #1 sponsor was "Shire" with 2 trials, followed by "Sight Sciences, Inc." with 2 trials sponsored, "Surface Ophthalmics, Inc." with 2 trials sponsored, "Claris Biotherapeutics, Inc." with 1 trials sponsored and "Dompé Farmaceutici S.p.A" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Kentucky Eye Institute


According to Clinical.Site data, the most researched conditions in "Kentucky Eye Institute" are "Dry Eye" (2 trials), "Dry Eye Disease" (2 trials), "Adenoviral Conjunctivitis" (1 trials), "Bacterial Conjunctivitis" (1 trials) and "Blepharitis" (1 trials). Many other conditions were trialed in "Kentucky Eye Institute" in a lesser frequency.

Clinical Trials Intervention Types at Kentucky Eye Institute


Most popular intervention types in "Kentucky Eye Institute" are "Drug" (7 trials), "Other" (4 trials), "Device" (3 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "PVP-I 0.6%" (2 trials), "SHP640" (2 trials), "0.02% Betamethasone Sodium Phosphate" (1 trials) and "0.04% Betamethasone Sodium Phosphate" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Kentucky Eye Institute


The vast majority of trials in "Kentucky Eye Institute" are 10 trials for "All" genders.

Clinical Trials Status at Kentucky Eye Institute


Currently, there are NaN active trials in "Kentucky Eye Institute". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Kentucky Eye Institute, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Kentucky Eye Institute, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status